Sociedad Americana de Hirudoterapia

Ministry of Health — Republic of Vanuatu

Vanuatu MoH · Vanuatu · oceania

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Vanuatu's Ministry of Health — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national pharmaceutical and medical device framework as appropriate, with practical reliance on PIC-cooperating reference jurisdictions.

Regulatory Profile

Agency type
national regulator
Region
oceania
Country
Vanuatu
Leech status
unregulated
Last ASH review
2026-05-27

Relevant Regulation Codes

  • Vanuatu Pharmacy (Control) Act [Cap. 116] and amendments
  • Pacific Island Countries (PIC) joint procurement arrangements through the Pacific Pharmaceutical Procurement Service where applicable

Prescriber Requirements

  • Vanuatu Medical Board–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Vanuatu MoH registration as applicable; English, French and Bislama-language labelling per local convention. Standard cold-chain conditions, with logistical constraints typical of remote Pacific island distribution.

Import/Export Rules

Vanuatu MoH and Department of Biosecurity Vanuatu clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Vanuatu's public health system coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Pacific island nations frequently rely on Australian TGA, New Zealand Medsafe and WHO-prequalified products via Pacific cooperation arrangements; whether this captures live-organism medical devices has not been independently mapped by ASH.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.